Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998
Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002
Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998
Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998
Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998
Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994
Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985
A Neuroleptic Malignantlike Syndrome Due to Levodopa Therapy Withdrawal
JAMA 254:2792-2795, Friedman,J.H.,et al, 1985
Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984
Dementia in Parkinson Disease
Ann Neurol 6:355-359, Lieberman,A.,et al, 1979
Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978